Syntegra Capital acquires Unither Pharmaceuticals, Inc.

On August 1, 2000, Syntegra Capital acquired Unither Pharmaceuticals, Inc., a life science company in Massachusetts, United States.

Deal at a glance

AnnouncedAugust 1, 2000 TypeBuyout (LBO, MBO, MBI) TargetUnither Pharmaceuticals, Inc. Buyer Syntegra Capital SectorLife Science LocationMassachusetts, United States ValueNot disclosed

Target company

Unither Pharmaceuticals, Inc.

Massachusetts, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Syntegra Capital

Private equity firm · 33 deals on record

1st transaction in life science
1st transaction in United States

33deals, all time

3in this sector

2011latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Unither Pharmaceuticals, Inc.?Syntegra Capital acquired Unither Pharmaceuticals, Inc. on August 1, 2000.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2000.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).